vs
CVB FINANCIAL CORP（CVBF）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
CVB FINANCIAL CORP的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.8倍（$133.8M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 8.4%），CVB FINANCIAL CORP自由现金流更多（$217.3M vs $14.4M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 2.8%）
CVB金融集团是一家美国银行控股公司，运营公民商业银行，主要服务加利福尼亚州市场，面向中小企业、专业机构及个人客户提供商业银行、个人银行、财富管理等多元金融服务，核心业务包含商业贷款、存款账户、资产管理等。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
CVBF vs PBYI — 直观对比
营收规模更大
CVBF
是对方的1.8倍
$75.5M
营收增速更快
PBYI
高出19.4%
8.4%
自由现金流更多
CVBF
多$203.0M
$14.4M
两年增速更快
PBYI
近两年复合增速
2.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $133.8M | $75.5M |
| 净利润 | — | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | 55.6% | 22.7% |
| 净利率 | — | — |
| 营收同比 | 8.4% | 27.7% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $0.41 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CVBFPBYI
| Q4 25 | $133.8M | $75.5M | ||
| Q3 25 | $128.6M | $54.5M | ||
| Q2 25 | $126.4M | $52.4M | ||
| Q1 25 | $126.7M | $46.0M | ||
| Q4 24 | $123.5M | $59.1M | ||
| Q3 24 | $126.5M | $80.5M | ||
| Q2 24 | $125.3M | $47.1M | ||
| Q1 24 | $126.6M | $43.8M |
净利润CVBFPBYI
| Q4 25 | — | — | ||
| Q3 25 | $52.6M | $8.8M | ||
| Q2 25 | $50.6M | $5.9M | ||
| Q1 25 | $51.1M | $3.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | $51.2M | $20.3M | ||
| Q2 24 | $50.0M | $-4.5M | ||
| Q1 24 | $48.6M | $-4.8M |
毛利率CVBFPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率CVBFPBYI
| Q4 25 | 55.6% | 22.7% | ||
| Q3 25 | 53.7% | 17.6% | ||
| Q2 25 | 54.4% | 12.7% | ||
| Q1 25 | 54.9% | 8.7% | ||
| Q4 24 | 55.1% | 22.6% | ||
| Q3 24 | 53.5% | 27.4% | ||
| Q2 24 | 54.9% | -4.6% | ||
| Q1 24 | 52.8% | -5.3% |
净利率CVBFPBYI
| Q4 25 | — | — | ||
| Q3 25 | 40.9% | 16.2% | ||
| Q2 25 | 40.0% | 11.2% | ||
| Q1 25 | 40.3% | 6.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | 40.5% | 25.2% | ||
| Q2 24 | 39.9% | -9.6% | ||
| Q1 24 | 38.4% | -11.0% |
每股收益（稀释后）CVBFPBYI
| Q4 25 | $0.41 | $0.26 | ||
| Q3 25 | $0.38 | $0.17 | ||
| Q2 25 | $0.37 | $0.12 | ||
| Q1 25 | $0.36 | $0.06 | ||
| Q4 24 | $0.36 | $0.40 | ||
| Q3 24 | $0.37 | $0.41 | ||
| Q2 24 | $0.36 | $-0.09 | ||
| Q1 24 | $0.35 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $376.4M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $2.3B | $130.3M |
| 总资产 | $15.6B | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资CVBFPBYI
| Q4 25 | $376.4M | $97.5M | ||
| Q3 25 | $783.9M | $94.4M | ||
| Q2 25 | $738.6M | $96.0M | ||
| Q1 25 | $529.1M | $93.2M | ||
| Q4 24 | $204.7M | $101.0M | ||
| Q3 24 | $453.5M | $96.7M | ||
| Q2 24 | $844.2M | $96.8M | ||
| Q1 24 | $949.6M | $107.2M |
总债务CVBFPBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益CVBFPBYI
| Q4 25 | $2.3B | $130.3M | ||
| Q3 25 | $2.3B | $115.3M | ||
| Q2 25 | $2.2B | $104.7M | ||
| Q1 25 | $2.2B | $97.1M | ||
| Q4 24 | $2.2B | $92.1M | ||
| Q3 24 | $2.2B | $71.1M | ||
| Q2 24 | $2.1B | $48.5M | ||
| Q1 24 | $2.1B | $51.0M |
总资产CVBFPBYI
| Q4 25 | $15.6B | $216.3M | ||
| Q3 25 | $15.7B | $202.9M | ||
| Q2 25 | $15.4B | $194.9M | ||
| Q1 25 | $15.3B | $196.2M | ||
| Q4 24 | $15.2B | $213.3M | ||
| Q3 24 | $15.4B | $220.7M | ||
| Q2 24 | $16.2B | $205.0M | ||
| Q1 24 | $16.5B | $214.1M |
负债/权益比CVBFPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $221.4M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $217.3M | $14.4M |
| 自由现金流率自由现金流/营收 | 162.4% | 19.1% |
| 资本支出强度资本支出/营收 | 3.0% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $391.5M | $41.7M |
8季度趋势，按日历期对齐
经营现金流CVBFPBYI
| Q4 25 | $221.4M | $14.4M | ||
| Q3 25 | $81.5M | $9.7M | ||
| Q2 25 | $53.1M | $14.1M | ||
| Q1 25 | $41.9M | $3.6M | ||
| Q4 24 | $249.8M | $15.6M | ||
| Q3 24 | $71.4M | $11.0M | ||
| Q2 24 | $26.1M | $1.0M | ||
| Q1 24 | $77.5M | $11.2M |
自由现金流CVBFPBYI
| Q4 25 | $217.3M | $14.4M | ||
| Q3 25 | $80.7M | $9.7M | ||
| Q2 25 | $52.3M | $14.1M | ||
| Q1 25 | $41.2M | $3.6M | ||
| Q4 24 | $244.6M | $15.6M | ||
| Q3 24 | $70.2M | $11.0M | ||
| Q2 24 | $24.4M | $1.0M | ||
| Q1 24 | $77.3M | — |
自由现金流率CVBFPBYI
| Q4 25 | 162.4% | 19.1% | ||
| Q3 25 | 62.8% | 17.7% | ||
| Q2 25 | 41.4% | 26.8% | ||
| Q1 25 | 32.5% | 7.7% | ||
| Q4 24 | 198.0% | 26.4% | ||
| Q3 24 | 55.5% | 13.7% | ||
| Q2 24 | 19.5% | 2.1% | ||
| Q1 24 | 61.1% | — |
资本支出强度CVBFPBYI
| Q4 25 | 3.0% | 0.0% | ||
| Q3 25 | 0.7% | 0.0% | ||
| Q2 25 | 0.7% | 0.0% | ||
| Q1 25 | 0.5% | 0.1% | ||
| Q4 24 | 4.2% | 0.0% | ||
| Q3 24 | 1.0% | 0.0% | ||
| Q2 24 | 1.4% | 0.0% | ||
| Q1 24 | 0.1% | 0.0% |
现金转化率CVBFPBYI
| Q4 25 | — | — | ||
| Q3 25 | 1.55× | 1.10× | ||
| Q2 25 | 1.05× | 2.41× | ||
| Q1 25 | 0.82× | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.39× | 0.54× | ||
| Q2 24 | 0.52× | — | ||
| Q1 24 | 1.59× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
